21 Oct ACG 2022 Annual Scientific Meeting, Charlotte, North Carolina

Close this search box.

HepaFat- Scan

HepaFat-Scan® Information for Patients

HepaFat-Scan is a magnetic resonance imaging (MRI)-based technology for the non-invasive measurement of liver fat. It provides a reliable measure of volume percentage of liver fat for screening, diagnosis, treatment planning and monitoring of patients in a variety of clinical settings. What Does HepaFat-Scan Offer You? A non-invasive – safe and painless alternative to liver […]

HepaFat-Scan® Information for Patients Read More »

clinical validation graph- HepaFat-Scan

HepaFat-Scan® Information for Clinicians

Potential Clinical Applications Gastroenterology and Hepatology Applications Initial workup for NAFLD diagnosis and for patient education and counselling. Liver fat analysis on patients already being screened or monitored for fibrosis or cirrhosis. Recent research indicates that patients with NAFLD and NASH can develop liver cancer without progressing through cirrhosis. Surgical Applications Scanning of patients with

HepaFat-Scan® Information for Clinicians Read More »